Litigation Details for Astellas Pharma Inc. v. Lupin Ltd. (D. Del. 2016)
✉ Email this page to a colleague
Astellas Pharma Inc. v. Lupin Ltd. (D. Del. 2016)
| Docket | ⤷ Try a Trial | Date Filed | 2016-10-07 |
| Court | District Court, D. Delaware | Date Terminated | 2020-04-29 |
| Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
| Jury Demand | None | Referred To | Christopher J. Burke |
| Patents | 6,346,532; 7,342,117; 7,982,049; 8,835,474; RE44,872 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Astellas Pharma Inc. v. Lupin Ltd.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Astellas Pharma Inc. v. Lupin Ltd. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-01-16 | 20 | 17 Page 9 of 25 PageID #: 147 Patent No. 6,346,532 (“the ’532 patent”) with respect to NDA No. 202611…Canadian Patent Publication No. CA2305802 to Maruyama et al. (“Maruyama”); U.S. Patent No. 6,346,532 C1 (…Orange Book lists the ’117 patent, the ’049 patent, the ’474 patent, the ’872 patent, and U.S. … United States Patent Nos. 7,342,117 (“the ’117 patent”), 7,982,049 (“the ’049 patent”), 8,835,474 (“…state a civil action for patent infringement arising under the United States patent laws, Title 35, United | External link to document | |
| 2020-04-29 | 27 | Order Dismissing Case | United States Patent Nos. 7,342,117, 7,982,049, 8,835,474, and RE44,872 (collectively Patents-in-suit) are…2016 29 April 2020 1:16-cv-00908 830 Patent None District Court, D. Delaware | External link to document |
| 2016-10-07 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,342,117 B2; 7,982,049 B2; 8,835,474… 7 October 2016 1:16-cv-00908 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
